FDA Inspection 1054286 — UC Reproductive Medicine at Kettering

UC Reproductive Medicine at Kettering — FEI 3003928248

The FDA completed an inspection of UC Reproductive Medicine at Kettering on May 16, 2018 in Kettering, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 16, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Kettering, OH (United States)